Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.

Authors:
S Singh A K Houng D Wang G L Reed

J Thromb Haemost 2016 09 6;14(9):1822-32. Epub 2016 Aug 6.

Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Unlabelled: Essentials Physiologic variations in blood plasminogen (Pg) levels may affect ischemic stroke outcomes. We tested Pg effects in a model with translational relevance to human thromboembolic stroke. A dose-response exists between Pg levels and brain injury, fibrinolysis, barrier breakdown. Higher Pg levels reduce microvascular thrombosis and improve outcomes in ischemic stroke.

Summary: Background and Objectives Plasminogen appears to affect brain inflammation, cell movement, fibrinolysis, neuronal excitotoxicity, and cell death. However, brain tissue and circulating blood plasminogen may have different roles, and there is wide individual variation in blood plasminogen levels. The aim of this study was to determine the integrated effect of blood plasminogen levels on ischemic brain injury. Methods We examined thromboembolic stroke in mice with varying, experimentally determined, blood plasminogen levels. Ischemic brain injury, blood-brain barrier breakdown, matrix metalloproteinase-9 expression and microvascular thrombosis were determined. Results Within the range of normal variation, plasminogen levels were strongly associated with ischemic brain injury; higher blood plasminogen levels had dose-related, protective effects. Higher plasminogen levels were associated with increased dissolution of the middle cerebral artery thrombus. Higher plasminogen levels decreased blood-brain barrier breakdown, matrix metalloproteinase-9 expression and microvascular thrombosis in the ischemic brain. In plasminogen-deficient mice, selective restoration of blood plasminogen levels reversed the harmful effects of plasminogen deficiency on ischemic brain injury. Specific inhibition of thrombin also reversed the effect of plasminogen deficiency on ischemic injury by decreasing microvascular thrombosis, blood-brain barrier breakdown, and matrix metalloproteinase-9 expression. Conclusions Variation in blood plasminogen levels, within the range seen in normal individuals, had marked effects on experimental ischemic brain injury. Higher plasminogen levels protected against ischemic brain injury, and decreased blood-brain barrier breakdown, matrix metalloproteinase-9 expression, and microvascular thrombosis. The protective effects of blood plasminogen appear to be mediated largely through a decrease in microvascular thrombosis in the ischemic territory.

Download full-text PDF

 Source
http://dx.doi.org/10.1111/jth.13390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035596PMC
September 2016

Publication Analysis

Top Keywords

plasminogen levels
48
blood plasminogen
40
microvascular thrombosis
28
ischemic brain
28
brain injury
28
barrier breakdown
20
plasminogen
17
breakdown matrix
16
blood-brain barrier
16
metalloproteinase-9 expression
16
matrix metalloproteinase-9
16
levels
14
higher plasminogen
12
expression microvascular
12
ischemic
11
brain
10
blood
10
physiologic variations
8
deficiency ischemic
8
plasminogen deficiency
8

Keyword Occurance

Similar Publications

Evaluation of Applicability of Novel Markers of Metabolic Syndrome in Adult Men.

Authors:
Ryszard Tomasiuk

Am J Mens Health 2022 Jul-Aug;16(4):15579883221108895

Faculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities in Radom, Radom, Poland.

There is a continuous worldwide increase in incidences of metabolic syndrome (MetS) reaching about a quarter of the world's population. Thus, studies that allow for a robust diagnosis of MetS are of paramount importance from an economic and medical point of view. This study was carried out in a group of men diagnosed with MetS using consensus definition criteria that included the definitions of the International Diabetes Foundation and Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score-matched analysis.

Authors:
Satoshi Gando Atsushi Shiraishi Takeshi Wada Kazuma Yamakawa Seitaro Fujishima Daizoh Saitoh Shigeki Kushimoto Hiroshi Ogura Toshikazu Abe Toshihiko Mayumi Junichi Sasaki Joji Kotani Naoshi Takeyama Ryosuke Tsuruta Kiyotsugu Takuma Shin-Ichiro Shiraishi Yasukazu Shiino Taka-Aki Nakada Kohji Okamoto Yuichiro Sakamoto Akiyoshi Hagiwara Satoshi Fujimi Yutaka Umemura Yasuhiro Otomo

Medicine (Baltimore) 2022 Aug;101(32):e29711

Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Japan.

Tranexamic acid (TXA) reduces the risk of bleeding trauma death without altering the need for blood transfusion. We examined the effects of TXA on coagulation and fibrinolysis dynamics and the volume of transfusion during the early stage of trauma. This subanalysis of a prospective multicenter study of severe trauma included 276 patients divided into propensity score-matched groups with and without TXA administration. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Altered Thermal Behavior of Blood Plasma Proteome Related to Inflammatory Cytokines in Early Pregnancy Loss.

Authors:
Regina Komsa-Penkova Avgustina Danailova Sashka Krumova Galya Georgieva Ina Giosheva Lidia Gartcheva Ivan Iliev Emil Gartchev Kameliya Kercheva Alexey Savov Svetla Todinova

Int J Mol Sci 2022 Aug 6;23(15). Epub 2022 Aug 6.

Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, "Acad. G. Bontchev" Str. 21, 1113 Sofia, Bulgaria.

Early pregnancy loss (EPL) is a relatively common pathology of which almost 50% of cases remain idiopathic. In the search for novel biomarkers, differential scanning calorimetry (DSC) is intensively used to characterize the thermodynamic behavior of blood plasma/serum proteome in health and disease. Herein, for the first time, we investigate the DSC denaturation profiles of blood plasma derived from patients suffering EPL compared to healthy pregnant and non-pregnant women. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.

Authors:
Jordan E Lake Ruibin Wang Benjamin W Barrett Emily Bowman Ana N Hyatt Paula Debroy Jury Candelario Linda Teplin Kaitlin Bodnar Heather McKay Michael Plankey Todd T Brown Nicholas Funderburg Judith S Currier

AIDS 2022 Aug 11. Epub 2022 Aug 11.

University of California Los Angeles, Los Angeles, CA, USA.

Background: Feminizing hormonal therapy (FHT) and HIV potentially alter cardiovascular disease (CVD) risk in transgender women (TW).

Methods: TW were enrolled in Los Angeles, CA and Houston, TX and frequency-matched to Multicenter AIDS Cohort Study cisgender men (CM) on age, race, substance use and abacavir use. Biomarkers of CVD risk and inflammation were assessed via ELISA. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Connexin 43 overexpression induces lung cancer angiogenesis following phosphorylation at Ser279 in its C-terminus.

Authors:
Zizi Zhou Wenxiang Chai Yi Liu Yao Liu Huiyu Pan Qiang Wu Xiaoming Zhang

Oncol Lett 2022 Sep 5;24(3):293. Epub 2022 Jul 5.

Department of Cardio-Thoracic Surgery, Shenzhen University General Hospital, Shenzhen, Guangdong 518055, P.R. China.

Blocking angiogenesis can inhibit tumor growth and metastasis. However, the mechanism underlying regulation of lung cancer angiogenesis remains unclear. The gap junction protein connexin 43 (Cx43) is implicated in angiogenesis. Read More

View Article and Full-Text PDF
September 2022
Similar Publications
}